combine@alvar.ug

Factors associated with Hepatitis B screening and completion of vaccination schedule among young psychoactive substance users in Kampala's informal settlements, Uganda

Factors associated with Hepatitis B screening and completion of vaccination schedule among young psychoactive substance users in Kampala's informal settlements, Uganda

Show simple record

dc.contributor.author Tonny Ssekamatte
dc.contributor.author John Bosco Isunju
dc.contributor.author Joan Nankya Mutyoba
dc.contributor.author Moses Tetui
dc.contributor.author Richard K. Mugambe
dc.contributor.author Aisha Nalugya
dc.contributor.author Brenda Wagaba
dc.contributor.author Patience Oputan
dc.contributor.author Justine Nnakate Bukenya
dc.contributor.author Esther Buregyeya
dc.contributor.author Simon P.S. Kibira
dc.date.accessioned 2021-01-11T13:51:50Z
dc.date.available 2021-01-11T13:51:50Z
dc.date.issued 2020
dc.identifier.uri https://combine.alvar.ug/handle/1/49627
dc.description.abstract Abstract; Background Young psychoactive substance users exhibit high-risk behaviours which can increase their risk to Hepatitis B infection. However, there is limited information on screening, and completion of the Hepatitis B vaccination schedule among young psychoactive substance users in informal settlements. Therefore, this study determined the factors associated with Hepatitis B screening, and completion of the Hepatitis B vaccination schedule among young psychoactive substance users in Kampala’s informal settlements, Uganda. Methods A cross-sectional study design was used. Respondent driven sampling was used to enroll 768 respondents from 12 informal settlements. Data were collected using a structured questionnaire and analysed using Stata version 14. A “modified” Poisson regression analysis was done to determine the factors associated with Hepatitis B screening while logistic regression was used to determine the factors associated with completion of the Hepatitis B vaccination schedule. Results Out of the 768 respondents, only 13.3% had ever screened for Hepatitis B and 2.7% had completed the Hepatitis B vaccine schedule. Being a female (aPR 1.61, 95% CI: 1.11-2.33), earning a monthly income >USD 136 (aPR 1.78, 95% CI: 1.11-2.86); completion of the Hepatitis B vaccination schedule (aPR 1.85, 95% CI: 1.26-2.70); lack of awareness about the recommended Hepatitis B vaccine dose (aPR 0.43, 95% CI: 0.27-0.68); and the belief that the Hepatitis B vaccine is effective in preventing Hepatitis B infection (aPR 3.67, 95% CI: 2.34-5.73) were associated with “ever screening” for Hepatitis B. Knowledge about the recommended Hepatitis B vaccine dose (aOR 0.06, 95% CI: 0.01-0.35); “ever screening” for hepatitis B (aOR 9.68, 95% CI: 2.17-43.16) and the belief that the hepatitis B vaccine is effective in preventing Hepatitis B infection (aOR 11.8, 95% CI: 1.13-110.14) were associated with completion of the Hepatitis B vaccination schedule. Conclusion Our findings indicate a low prevalence of Hepatitis B screening and completion of the Hepatitis B vaccination schedule among young psychoactive substance users in informal urban settings. It is evident that lack of awareness about Hepatitis B is associated with the low screening and vaccination rates. We recommend mass sensitisation of young psychoactive substance users in urban informal settlements on Hepatitis B.
dc.publisher Research Square
dc.title Factors associated with Hepatitis B screening and completion of vaccination schedule among young psychoactive substance users in Kampala's informal settlements, Uganda
dc.type Preprint
dc.identifier.doi 10.21203/rs.3.rs-15918/v1
dc.identifier.lens 081-896-957-618-265


This record appears in the collections of the following institution(s)

Show simple record

Search Entire Database


Browse

My Account